Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease
Chronic graft-versus-host disease (GVHD) occurs in 30–70% of patients after allogeneic hematopoietic cell transplantation (HCT) and increases the risks of morbidity and mortality. Systemic corticosteroids are the standard initial treatment, but one-third of patients require subsequent treatment with...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2025-02-01
|
| Colección: | Cells |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2073-4409/14/4/238 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
